ZappRx has raised a Series A round to support sales and product development for its specialty pharmaceutical portal. SR One, the venture arm of GlaxoSmithKline, led the $5.6 million fundraise, along with Atlas Venture. It also added former Teva Pharmaceuticals CEO Jeremy Levin to its board. The point of ZappRx’s platform is to improve communication and […]
When science fiction creeps toward a disturbing potential reality, it makes for very good TV. Season 3 of the BBC’s Orphan Black returns April 18, satiating fans of the action-packed, conspiracy drama that’s delivered with a beautiful biotech backdrop. A fringe research foundation has peppered the earth with a series of human clones. Some of […]
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Leading newspapers, including the Wall St. Journal and New York Times, misunderstand the strategy behind Pfizer’s proposed purchase of Hospira. Here’s what the Journal had to say: Pfizer Inc. said Thursday it would buy smaller rival Hospira Inc. in a $16 billion deal that would transform the New York pharmaceutical company into a leading player […]
After decades of stagnancy in the herpes therapeutics space, a real neck-and-neck race is emerging among three biotechs in the immunotherapy space: Genocea and Agenus, both based in Massachusetts, San Diego’s Vical are speeding ahead in developing a herpes vaccine. The idea for these companies is to develop a therapeutic vaccine targeted toward individuals who already have […]
A drug developer is working on a compound that could be used to treat patients with anesthesia induced respiratory depression following surgery. It’s a life threatening condition for which elderly, obese and patients with obstructive sleep apnea are at high risk. The condition can be caused in part by underlying medical conditions and medications patients might […]